Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
07 Nov 2014 Olaparib in Patients with BRCA-Related Cancers Cancer in Special Situations - Anticancer agents & Biologic therapy
06 Nov 2014 Facilitating Global Development of Biosimilars Bioethics, legal and economic issues
05 Nov 2014 Ipilimumab Plus Sargramostim in Metastatic Melanoma Melanoma - Immuno-oncology
03 Nov 2014 Genomic Landscape of ccRCC in Central Europe Genitourinary cancers - Translational research
31 Oct 2014 Genomic Landscape of Papillary Thyroid Carcinoma Translational research - Endocrine cancers
30 Oct 2014 Study May Explain Why Erlotinib Doesn't Benefit Patients With Early-Stage Lung Cancer Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Oct 2014 Hormone Therapy Adherence in Early-Stage Breast Cancer Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
28 Oct 2014 EMA Adopts a Positive Opinion for a New Indication for Enzalutamide Genitourinary cancers - Anticancer agents & Biologic therapy
27 Oct 2014 EMA Recommends Granting a Marketing Authorisation for Olaparib Gynaecologic malignancies - Anticancer agents & Biologic therapy
22 Oct 2014 New Safety Labelling Changes Approved By FDA Center for Drug Evaluation and Research Anticancer agents & Biologic therapy
20 Oct 2014 Information on Suspected Side Effects of EU Nationally Authorised Medicines Now Available Through a Single Website Bioethics, legal and economic issues
17 Oct 2014 EMA Adopts Landmark Policy on Publication of Clinical Reports Bioethics, legal and economic issues
15 Oct 2014 Harnessing 3D Imagery for Early Tumour Detection Imaging
14 Oct 2014 EMA’s Pharmacovigilance Risk Assessment Committee Recommends Further Measures to Minimise Risk of Thrombosis and Occlusion of Blood Vessels With Ponatinib Haematologic malignancies - Anticancer agents & Biologic therapy
13 Oct 2014 FDA Approves an Oral Combination of Netupitant and Palonosetron for Nausea and Vomiting Associated With Cancer Chemotherapy Palliative and supportive care